This tissue dynamic (i.e. chondrocyte hypertrophy leading to VEGF-dependent neovascularization) is likely unique to bone healing, and may explain why impaired vascularization in other situations, such as during dermal wound healing [55], [56], is a phenotype shared by T1DM and T2DM. The gene discussed is VEGFA; the disease is type 2 diabetes mellitus.